Search bioRxiv⌕ Search

Biology subjects

Soic, D.

Publications and source records attributed to Soic, D..

2 recordsLinked to original sources

NovoGlyco: mapping protein glycosylation in prokaryotes

Protein glycosylation in prokaryotes shows extraordinary diversity including species-specific monosaccharides, non-canonical attachment sites, and variable glycan architectures that challenge existing glycoproteomics approaches. Current strategies are largely tailored to eukaryotic systems and depend on predefined glycan databases or prior biochemical knowledge, limiting their application to microbes. Here we present NovoGlyco, a modular glycoproteomics platform for untargeted characterisation of prokaryotic protein glycosylation from shotgun proteomics data. NovoGlyco integrates de novo oxonium ion discovery, sequence tag matching, and mass offset binning to identify novel glycans, their composition, and linking chemistry. An interactive dashboard allows exploration of glycan features and modified proteins. We demonstrate the NovoGlyco platform across published glycoproteomics datasets, spanning human pathogens, Asgard archaea, and environmental enrichment cultures, and identify previously unreported flagella O-glycans in the opportunistic pathogen Campylobacter fetus. In summary, NovoGlyco provides a scalable framework for unbiased exploration of microbial glycoproteomes in both single-organism and metaproteomic contexts.

systems biology↗

High-Throughput Site-Specific N-Glycosylation Profiling of Human Fibrinogen in Atrial Fibrillation

Fibrinogen is a major plasma glycoprotein involved in blood coagulation and inflammatory responses. Alterations in its glycosylation have been implicated in various pathological conditions, yet its site-specific N-glycosylation profile remains largely unexplored in a clinical context. Here, we present a high-throughput LC-MS workflow for site-specific analysis of fibrinogen N-glycosylation using a cost-effective ethanol precipitation enrichment method. The method demonstrated good intra- and inter-plate repeatability (CV: 5% and 12%, respectively) and was validated through the first assessment of intraindividual temporal stability in healthy individuals, revealing consistent glycosylation patterns within individuals. Application to 181 atrial fibrillation (AF) patients and 52 healthy controls identified three gamma chain glycoforms significantly associated with AF. Most notably, increased levels of the asialylated N4H5, known to enhance fibrin bundle thickness and promote clot formation, suggest a potential mechanism linking glycosylation changes to the prothrombotic state in AF. Furthermore, fibrinogen sialylation showed strong associations with cardiovascular risk factors, including triglycerides, BMI, and glucose levels. Longitudinal analysis of 108 AF patients six months post-catheter ablation showed stability in the AF-associated glycan profile. Our findings establish fibrinogen glycosylation as a potential biomarker for cardiovascular conditions and demonstrate the utility of site-specific glycosylation analysis for clinical applications.

molecular biology↗